A recent study has shown that the persistence of measurable C-peptide during follow-up, as well as the presence of positive family history for diabetes and a reduced insulin requirement (<0.5 IU/kg/day), are the best markers to distinguish MODY from T1DM (50). This evidence concerns the gene INS and MODY.